1. "Breast Medicine Service"
  2. "Mark Robson"
  3. "Hannah Wen"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (15)
  3. Review (1)
Groups
  1. Breast Medicine Service (33)
  2. Department of Medicine (33)
  3. Population Sciences Research Program (33)
  4. Solid Tumor Oncology Division (33)
  5. Survivorship Research (33)
  6. GSK Faculty (23)

More Groups

People
  1. Hannah Wen (33)
  2. Mark Robson (33)
  3. Edi Brogi (25)
  4. Larry Norton (21)
  5. Jorge Reis-Filho (17)
  6. Britta Weigelt (11)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (8)

More Years

Publications
  1. Laboratory Investigation (7)
  2. Journal of Clinical Oncology (5)
  3. npj Breast Cancer (5)
  4. Modern Pathology (4)
  5. Breast Cancer Research and Treatment (3)
  6. Cancer Research (2)

More Publications

Publishers
  1. Nature Publishing Group (12)
  2. American Society of Clinical Oncology (5)
  3. Nature Research (4)
  4. American Association for Cancer Research (3)
  5. Oxford University Press (3)
  6. Springer (3)

More Publishers

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of reactive changes on multigene testing: Histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores
    Journal Article

    Grabenstetter, A.; Brogi, E.; Thompson, D. M.; Blinder, V. S.; Norton, L.; Morrow, M.; Robson, M. E.; Wen, H. Y.
    Breast Cancer Research and Treatment (2024)

    Fulltext@MSK | Save
  • Prognostic implications of HER2 gain in patients with HR+/ HER2-breast cancer (BC) and TNBC after neoadjuvant chemotherapy (NAC)
    Meeting Abstract

    Ferraro, E.; Chew Minmin, S.; Nemirovsky, D.; Chen, Y.; Barrio, A. V.; Modi, S.; Seidman, A.; Wen, H.; Brogi, E.; Robson, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Invasive disease free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Meeting Abstract

    Chew, S.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D. W.; Modi, S.; Seidman, A. D.; Wen, H. Y.; Brogi, E.; Robson, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prospective evaluation of pathologic response with neoadjuvant chemo-immunotherapy in metaplastic breast cancer
    Meeting Abstract

    Abuhadra, N.; Chen, Y.; Plitas, G.; Razavi, P.; Pareja, F.; Reis-Filho, J. S.; Wen, H. Y.; Khan, A. J.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The histologic and genomic features of breast cancers harboring genetic alterations in RecQ DNA helicases
    Meeting Abstract

    Kaur, G.; Selenica, P.; Gazzo, A.; Cartagena, L. C.; Daaboul, F.; Dopeso, H.; da Silva, E. M.; Ross, D.; Zhang, H.; Wen, H.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Morphologic and genomic characteristics of breast cancers occurring in individuals with Lynch syndrome
    Journal Article

    Schwartz, C. J.; da Silva, E. M.; Marra, A.; Gazzo, A. M.; Selenica, P.; Rai, V. K.; Mandelker, D.; Pareja, F.; Misyura, M.; D'Alfonso, T. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
    Review

    El Bairi, K.; Haynes, H. R.; Blackley, E.; Fineberg, S.; Shear, J.; Turner, S.; de Freitas, J. R.; Sur, D.; Amendola, L. C.; Gharib, M.; more...
    npj Breast Cancer (2021)

    Fulltext@MSK | Save
  • Change in HER2 status after neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in patients with HER2-positive early-stage breast cancer
    Meeting Abstract

    Ferraro, E.; Razavi, P.; Chandarlapaty, S.; Modi, S.; Wen, H. Y.; Brogi, E.; Norton, L.; Robson, M. E.; Dang, C. T.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • PD-L1 expression in metaplastic breast carcinoma using the PD-L1 SP142 assay and concordance among PD-L1 immunohistochemical assays
    Journal Article

    Grabenstetter, A.; Jungbluth, A. A.; Frosina, D.; Hoda, R.; Dos Anjos, C. H.; Patil, S.; Sevilimedu, V.; Weigelt, B.; Reis-Filho, J. S.; Zhang, H.; more...
    American Journal of Surgical Pathology (2021)

    Fulltext@MSK | Save